AimedBio shares have soared since listing, positioning Intervest for a potential tenfold return on its 40 billion won investment, pending lock-up expirations.
#YonhapInfomax #AimedBio #Intervest #Tenbagger #IPO #ConvertiblePreferredShares #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=94331
#YonhapInfomax #AimedBio #Intervest #Tenbagger #IPO #ConvertiblePreferredShares #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=94331